Stuart M. Essig, PhD
Chairman of the Board
Independent Director since July 2017
Finance Committee (Chair)
Governance and Corporate Responsibility Committee
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Dr. Essig has served as the Chair of the Board of Directors of Integra LifeSciences Holdings Corporation since January 2012, and he first joined Integra’s Board of Directors in December 1997. In addition, Dr. Essig was Integra’s Chief Executive Officer from December 1997 until June 2012. Since 2012, he has also served as Managing Director of Prettybrook Partners LLC, a family office focused on investing in the healthcare industry. He is a Venture Partner at Wellington Partners Advisory AG, a venture capital firm, and a Senior Advisor to TowerBrook Capital Partners and Water Street Healthcare Partners. Before joining Integra, Dr. Essig was a managing director in mergers and acquisitions for Goldman, Sachs and Co., specializing in the medical device, pharmaceutical and biotechnology sectors. Dr. Essig has served as a member of the board of directors of Orthofix Medical Inc. since January 2023 following its merger with SeaSpine Holdings Corporation where Dr. Essig served as a member of the board of directors from June 2015 to January 2023 (serving as its Lead Director from July 2015 to January 2023). Dr. Essig was a member of the boards of directors of Owens & Minor, Inc. from 2013 until 2019, St. Jude Medical, Inc. from 1999 to 2017, Vital Signs, Inc. from 1998 to 2002 and Zimmer Biomet Holdings, Inc. from 2005 to 2008. Dr. Essig holds an undergraduate degree from the Woodrow Wilson School of Public and International Affairs at Princeton University and a PhD in financial economics and an MBA from the University of Chicago.